Exploring the Link Between Innovative Payment Schemes & Real World Evidence (RWE) in Supporting Gene Therapy Value & Approval Processes

Time: 11:00 am
day: Day 2 Track B Morning


  • Setting the context of innovative payment model approaches in Europe and links to RWE
  • Exploring how recent pan-European legislation relates to gene therapy market access
  • How are different European countries approaching market access in practice?